玻璃化市场：按产品类型、应用、最终用户和地区划分

2024 年全球玻璃化市场规模估计为 93 亿美元，预计 2031 年将达到 265.1 亿美元，2024 年至 2031 年的复合年增长率为 16.1%。

图。

由于全球对辅助生殖技术（ART）的需求不断增加，全球玻璃化冷冻市场正在稳步成长。玻璃化冷冻是一种先进的冷却技术，用于冷冻和保存人类卵子、胚胎和卵巢组织以进行体外受精。该过程使生物样本极其迅速地冷却成玻璃状固体，而不会形成结晶，从而保持其活力。由于不孕不育率的上升、用于治疗不孕不育的医疗旅游基础的扩大、以及与传统慢速冷冻技术相比玻璃化冷冻试管受精週期的成功率的提高，预计未来十年全球玻璃化冷冻市场将以显着的速度增长。

市场动态：

全球玻璃化冷冻市场的发展受到全球不孕症盛行率上升的推动。根据世界卫生组织估计，到2023年4月，全球将有约4,800万夫妇遭受不孕症问题的困扰。此外，生育延迟、压力增加、肥胖、性行为感染传染病和其他生活方式因素也导致不孕率上升。例如，根据美国国家医学图书馆 2022 年 2 月的报告，15 个欧洲国家透过公共医疗保险完全或部分涵盖 IVF 週期。然而，玻璃化冷冻的高成本、对人体组织冷冻保存的伦理问题以及发展中地区的认知度低是限制该技术广泛应用的一些因素。此外，对提供生育治疗的医疗机构的严格规定也给市场相关人员带来了挑战。随着持续的研究和开发专注于开发更有效率的玻璃化解决方案，市场预计将迎来丰厚的利润机会。市场领导正在投资开放和封闭玻璃化系统以及更好的冷冻保护剂等技术，以提高玻璃化循环的成功率。低成本国家医疗旅游业的发展和新兴经济体可支配收入的提高将在未来几年进一步推动对 ART 的需求。

本研究的主要特点

本报告对全球玻璃化治疗市场进行了详细分析，并展示了预测期（2024-2031 年）的市场规模（十亿美元）和年复合成长率（CAGR%），以 2023 年为基准年。

它揭示了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。

它还提供了关于市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的主要考察。

全球玻璃化市场的主要企业根据公司亮点、产品系列、关键亮点、性能和策略等参数进行分析。

研究中介绍的主要企业包括 Vitrolife AB、CooperSurgical, Inc.、Merck KGaA、Ferring Pharmaceuticals、Igenomix、Genea Biomedx、Cryoport, Inc.、Kitazato Corporation、ReproTech, LLC、Thermo Fisher Scientific、EMD Serono、OvaScience, Inc., 清零组合、Medline Inc. 和

本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。

全球玻璃化市场报告涵盖该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。

相关人员将透过用于分析全球玻璃化市场的各种策略矩阵来做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章市场动态、法规与趋势分析

• 市场动态
• 驱动程式
• 限制因素
• 机会
• 影响分析
• 主要进展
• 监管情景
• 产品发布/核准
• PEST分析
• PORTER 分析
• 併购情景
• 产业趋势

4. 2019 年至 2031 年全球玻璃化市场（依产品类型）

• 玻璃化溶液
• 玻璃化冷冻设备
• 其他产品类型

5. 全球玻璃化市场，依应用，2019 年至 2031 年

• 体外受精（IVF）
• 干细胞保存
• 其他应用

6. 全球玻璃化市场，依最终用户划分，2019 年至 2031 年

• 不孕不育诊所
• 医院和诊断中心
• 研究组织
• 生物库
• 其他的

7. 2019 年至 2031 年全球玻璃化市场（按地区）

• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第八章 竞争格局

• Vitrolife AB
• CooperSurgical, Inc.
• Merck KGaA
• Ferring Pharmaceuticals
• Igenomix
• Genea Biomedx
• Cryoport, Inc.
• Kitazato Corporation
• ReproTech, LLC
• Thermo Fisher Scientific
• EMD Serono
• OvaScience, Inc.
• LifeGlobal
• Medline Industries, Inc.
• Reproductive Health Technologies

第 9 章分析师建议

• 命运之轮
• 分析师观点
• 一致的机会图

第十章参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

The global vitrification market is estimated to be valued at USD 9.30 Bn in 2024 and is expected to reach USD 26.51 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 16.1% from 2024 to 2031.

Figure. Vitrification Market Share (%), By Region 2024

The global vitrification market is witnessing a steady growth owing to rising demand for assisted reproductive technologies (ART) across the globe. Vitrification is an advanced cooling technique used for cryopreservation of human eggs, embryos, and ovarian tissue during IVF procedures. This process involves extremely rapid cooling of biological samples to glassy solidity without any ice crystal formation, thereby preserving viability. With rising infertility rates, expanding base of medical tourism for fertility treatments, and improving success rates of vitrified IVF cycles compared to conventional slow freezing techniques, the global vitrification market is estimated to grow at a significant pace over the next decade.

Market Dynamics:

The global vitrification market is driven by rising prevalence of infertility worldwide. In April 2023, according to WHO, around 48 million couples globally suffered from infertility issues. Additionally, delaying parenthood, increasing stress levels, obesity, sexually transmitted diseases, and other lifestyle factors are contributing to higher infertility rates. For instance, yn February 2022, according to the National Library of Medicine, 15 European nations provide full or partial coverage of IVF cycles under public health insurance. However, high cost of vitrification procedure, ethical concerns regarding cryopreservation of human tissues, and lack of awareness in developing regions are some of the factors restricting broader adoption of this technology. Moreover, stringent regulations for health facilities providing fertility treatments pose challenges for market players. With ongoing R&D focusing on developing more efficient vitrification solutions, the market is expected to witness lucrative opportunities. Market leaders are investing in technologies such as open versus closed vitrification systems and better cryoprotectants to improve success rates of vitrified cycles. Increasing medical tourism in low-cost countries and rising disposable income in developing nations will further support the demand for ART in the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global vitrification market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global vitrification market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Vitrolife AB, CooperSurgical, Inc., Merck KGaA, Ferring Pharmaceuticals, Igenomix, Genea Biomedx, Cryoport, Inc., Kitazato Corporation, ReproTech, LLC, Thermo Fisher Scientific, EMD Serono, OvaScience, Inc., LifeGlobal, Medline Industries, Inc., and Reproductive Health Technologies

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global vitrification market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vitrification market

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Vitrification Solutions
  • Vitrification Equipment
  • Other Related Products
• Application Insights (Revenue, USD Bn, 2019 - 2031)
  • In Vitro Fertilization (IVF)
  • Stem Cell Preservation
  • Other Applications
• End User Insights (Revenue, USD Bn, 2019 - 2031)
  • Fertility Clinics
  • Hospitals and Diagnostic Centers
  • Research Institutes
  • Biobanks
  • Others
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Key Players Insights
  • Vitrolife AB
  • CooperSurgical, Inc.
  • Merck KGaA
  • Ferring Pharmaceuticals
  • Igenomix
  • Genea Biomedx
  • Cryoport, Inc.
  • Kitazato Corporation
  • ReproTech, LLC
  • Thermo Fisher Scientific
  • EMD Serono
  • OvaScience, Inc.
  • LifeGlobal
  • Medline Industries, Inc.
  • Reproductive Health Technologies

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Vitrification Market, By Product Type
  • Global Vitrification Market, By Application
  • Global Vitrification Market, By End User
  • Global Vitrification Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Vitrification Market, By Product Type, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Vitrification Solutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Vitrification Equipment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Other Related Products
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Vitrification Market, By Application, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• In Vitro Fertilization (IVF)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Stem Cell Preservation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Other Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Vitrification Market, By End User, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Fertility Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Hospitals and Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Biobanks
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Vitrification Market, By Region, 2019 - 2031, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Vitrolife AB
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• CooperSurgical, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ferring Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Igenomix
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Genea Biomedx
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cryoport, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Kitazato Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• ReproTech, LLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• EMD Serono
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• OvaScience, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• LifeGlobal
• Medline Industries, Inc.
• Reproductive Health Technologies

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us